MINUTOLO, Roberto
 Distribuzione geografica
Continente #
EU - Europa 15.358
NA - Nord America 11.174
AS - Asia 7.115
SA - Sud America 1.070
Continente sconosciuto - Info sul continente non disponibili 383
AF - Africa 91
OC - Oceania 8
Totale 35.199
Nazione #
US - Stati Uniti d'America 10.974
RU - Federazione Russa 9.757
SG - Singapore 2.414
IE - Irlanda 1.598
CN - Cina 1.510
HK - Hong Kong 1.068
IT - Italia 1.063
BR - Brasile 902
UA - Ucraina 830
GB - Regno Unito 707
VN - Vietnam 690
IN - India 522
DE - Germania 469
KR - Corea 276
FI - Finlandia 238
TR - Turchia 229
SE - Svezia 220
GR - Grecia 127
CA - Canada 102
JP - Giappone 94
BD - Bangladesh 89
FR - Francia 89
AR - Argentina 55
AT - Austria 54
BE - Belgio 38
NL - Olanda 35
MX - Messico 33
ES - Italia 31
EC - Ecuador 30
IQ - Iraq 30
CZ - Repubblica Ceca 26
PK - Pakistan 25
ZA - Sudafrica 24
ID - Indonesia 22
CO - Colombia 19
PH - Filippine 19
VE - Venezuela 19
MA - Marocco 15
MY - Malesia 15
PY - Paraguay 15
CL - Cile 14
JM - Giamaica 14
CR - Costa Rica 13
SA - Arabia Saudita 13
IR - Iran 12
UZ - Uzbekistan 12
NI - Nicaragua 10
KZ - Kazakistan 9
LT - Lituania 9
PL - Polonia 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
TH - Thailandia 8
TN - Tunisia 8
UY - Uruguay 8
CH - Svizzera 7
EG - Egitto 7
IL - Israele 7
SC - Seychelles 7
EU - Europa 6
PT - Portogallo 6
RO - Romania 6
RS - Serbia 6
AU - Australia 5
EE - Estonia 5
HN - Honduras 5
NP - Nepal 5
TW - Taiwan 5
AL - Albania 4
BG - Bulgaria 4
GE - Georgia 4
JO - Giordania 4
OM - Oman 4
PE - Perù 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BO - Bolivia 3
ET - Etiopia 3
GA - Gabon 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
GT - Guatemala 2
KH - Cambogia 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
RW - Ruanda 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UG - Uganda 2
AD - Andorra 1
AO - Angola 1
Totale 34.790
Città #
Moscow 3.478
Dublin 1.595
Jacksonville 1.247
San Jose 1.085
Hong Kong 1.057
Santa Clara 1.033
Singapore 967
Chandler 896
Ashburn 803
Council Bluffs 623
Chicago 496
Bengaluru 461
Princeton 275
Seoul 262
Hefei 254
Ho Chi Minh City 241
Wilmington 224
Medford 207
Milan 191
Beijing 177
Hanoi 170
Dallas 164
Boardman 155
Roxbury 150
Ann Arbor 139
Falls Church 133
San Mateo 121
Naples 106
Los Angeles 98
Woodbridge 98
The Dalles 96
New York 94
São Paulo 93
Munich 63
Des Moines 58
Nanjing 58
Istanbul 56
Caserta 54
Bremen 53
Miano 41
Atlanta 40
Cambridge 40
Jinan 39
Brussels 38
Da Nang 38
Houston 37
Rome 37
Haiphong 32
Saint Petersburg 32
Tokyo 29
Mountain View 28
Belo Horizonte 27
Frankfurt am Main 26
Norwalk 26
Nuremberg 26
Zhengzhou 26
Napoli 25
Tianjin 25
Vienna 25
Rio de Janeiro 24
Shenyang 24
Toronto 24
Guangzhou 23
Brno 22
North Bergen 22
Orem 21
Brooklyn 20
Helsinki 20
Ercolano 19
Turku 19
Bologna 18
Curitiba 18
Shanghai 17
Changsha 16
Hangzhou 16
Montreal 16
Chennai 15
London 15
Phoenix 15
Falkenstein 14
Seattle 14
Florence 13
Johannesburg 13
Nanchang 13
Ningbo 13
Philadelphia 13
Auburn Hills 12
Boston 12
Hải Dương 12
Miami 12
San Francisco 12
Columbus 11
Nha Trang 11
Queens 11
Taizhou 11
Amsterdam 10
Charlotte 10
Dhaka 10
Kingston 10
Memphis 10
Totale 18.799
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 843
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis 484
Empagliflozin in Patients with Chronic Kidney Disease 256
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 244
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 204
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 187
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 187
Amino acid loss during dialysis treatment 187
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 181
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 180
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 177
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 177
[Anti-diabetics and chronic kidney disease] 176
[Hyperuricaemia and Chronic Kidney Disease] 176
[Iron deficiency in ND-CKD: from diagnosis to treatment] 174
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 173
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 172
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 171
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 170
AISF position paper on HCV in immunocompromised patients 170
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 168
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 167
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 167
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 166
Daily nutrient intake in hemodialysis. 166
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 165
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 165
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 164
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 164
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 163
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 162
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 161
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 160
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 160
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 159
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 158
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 158
[Epidemiology and prognosis of chronic kidney disease in Italy] 156
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 154
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 154
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 154
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 152
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 150
Disfunzione renale nell’anziano: processo fisiologico o malattia? 148
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 148
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 147
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 147
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 145
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 145
Management of hypertension in chronic kidney disease: the Italian multicenter study. 145
Epidemiology of chronic kidney disease in Italy: the CARHES study 145
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 145
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 145
Epidemiology of CKD Regression in Patients under Nephrology Care 145
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 145
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 144
Anemia: A Connection Between Heart Failure and Kidney Failure 144
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 143
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 143
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. 142
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 141
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 141
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 140
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 140
ESA, iron therapy and new drugs: Are there new perspectives in the treatment of anaemia? 140
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 139
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 139
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 138
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed 137
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 137
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 136
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 136
Management of hypertension in chronic kidney disease 136
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 136
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 136
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe 135
Epidemiology of chronic kidney disease in Italy 135
[Antihypertensive treatment in the nephropathic patient] 135
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 135
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 135
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses 134
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 134
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 134
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 134
Are all erythropoiesis-stimulating agents created equal? 134
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 133
Heart Failure in chronic kidney disease: from epidemiology to therapy. 133
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 132
Effects of age on hypertensive status in patients with chronic kidney disease 132
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 132
Prevalence and renal prognosis of left ventricular diastolic dysfunction in non-dialysis chronic kidney disease patients with preserved systolic function 131
Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis 130
Clinical policies on the management of chronic kidney disease patients in Italy 130
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 130
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 129
Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency 128
Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD 128
Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials 128
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 128
Inibizione dell’angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 128
Totale 16.217
Categoria #
all - tutte 119.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.522 0 0 0 72 523 15 36 51 64 144 158 459
2022/20233.530 315 108 313 287 327 289 9 211 1.496 36 62 77
2023/20241.205 116 44 53 113 447 63 29 20 17 23 84 196
2024/20254.103 12 72 59 121 648 577 586 346 446 671 315 250
2025/202616.859 699 1.029 854 751 1.291 9.172 874 795 610 393 230 161
2026/20273.269 370 458 1.348 1.093 0 0 0 0 0 0 0 0
Totale 35.199